A New Affinity-Based Probe to Profile MMP Active Forms.

Affinity-based probes Mass spectrometry Matrix metalloproteinases Streptavidin-based enrichment

Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2024
Historique:
medline: 4 12 2023
pubmed: 1 12 2023
entrez: 1 12 2023
Statut: ppublish

Résumé

A new generation of affinity-based probes (AfBPs) has been developed to label and identity matrix metalloproteinases (MMPs) under their active form in complex proteomes. First, the probe reacts with an active MMP through a proximity-driven reaction that does not require any external trigger. Following this affinity-labeling step, a streptavidin-based enrichment of the resulting biotin-tagged MMP is carried out. Finally, after on-beads proteolytic digestion by trypsin, MMP signature peptides are analyzed and identified by mass spectrometry. Such a "photoactivation-free" labeling can be applied to the detection of several MMPs in a wide variety of biological systems, including in vivo conditions.

Identifiants

pubmed: 38038929
doi: 10.1007/978-1-0716-3589-6_3
doi:

Substances chimiques

Matrix Metalloproteinases EC 3.4.24.-
Streptavidin 9013-20-1
Biotin 6SO6U10H04

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

29-39

Informations de copyright

© 2024. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141:52–67
doi: 10.1016/j.cell.2010.03.015 pubmed: 20371345 pmcid: 2862057
Almeida LGN, Thode H, Eslambolchi Y et al (2022) Matrix metalloproteinases: from molecular mechanisms to physiology, pathophysiology, and pharmacology. Pharmacol Rev 74:712–768
doi: 10.1124/pharmrev.121.000349 pubmed: 35738680
Dufour A, Overall CM (2013) Missing the target: matrix metalloproteinase antitargets in inflammation and cancer. Trends Pharmacol Sci 34:233–242
doi: 10.1016/j.tips.2013.02.004 pubmed: 23541335
Chan EWS, Chattopadhaya S, Panicker RC et al (2004) Developing photoactive affinity probes for proteomic profiling: hydroxamate-based probes for metalloproteases. J Am Chem Soc 126:14435–14446
doi: 10.1021/ja047044i pubmed: 15521763
Saghatelian A, Jessani N, Joseph A et al (2004) Activity-based probes for the proteomic profiling of metalloproteases. Proc Natl Acad Sci U S A 101:10000–10005
doi: 10.1073/pnas.0402784101 pubmed: 15220480 pmcid: 454150
Sieber SA, Niessen S, Hoover HS et al (2006) Proteomic profiling of metalloprotease activities with cocktails of active-site probes. Nat Chem Biol 2:274–281
doi: 10.1038/nchembio781 pubmed: 16565715 pmcid: 1538544
David A, Steer D, Bregant S et al (2007) Cross-linking yield variation of a potent matrix metalloproteinase photoaffinity probe and consequences for functional proteomics. Angew Chem Int Ed Engl 46:3275–3277
doi: 10.1002/anie.200604408 pubmed: 17387672
Bregant S, Huillet C, Devel L et al (2009) Detection of matrix metalloproteinase active forms in complex proteomes: evaluation of affinity versus photoaffinity capture. J Proteome Res 8:2484–2494
doi: 10.1021/pr801069c pubmed: 19271733
Geurink PP, Prely LM, Marel GA et al (2012) Photoaffinity labeling in activity-based protein profiling. Top Curr Chem 324:85–113
doi: 10.1007/128_2011_286 pubmed: 22028098
Nury C, Czarny B, Cassar-Lajeunesse E et al (2013) A pan photoaffinity probe for detecting active forms of matrix metalloproteinases. Chembiochem 14:107–114
doi: 10.1002/cbic.201200583 pubmed: 23203916
Ravindra KC, Ahrens CC, Wang Y et al (2018) Chemoproteomics of matrix metalloproteases in a model of cartilage degeneration suggests functional biomarkers associated with posttraumatic osteoarthritis. J Biol Chem 293:11459–11469
doi: 10.1074/jbc.M117.818542 pubmed: 29794029 pmcid: 6065175
Ahrens CC, Chiswick EL, Ravindra KC et al (2019) Development and application of the metalloprotease activity multiplexed bead-based immunoassay (MAMBI). Biochemistry 58:3938–3942
doi: 10.1021/acs.biochem.9b00584 pubmed: 31474112
Nury C, Bregant S, Czarny B et al (2013) Detection of endogenous matrix metalloprotease-12 active form with a novel broad spectrum activity-based probe. J Biol Chem 288:5636–5644
doi: 10.1074/jbc.M112.419499 pubmed: 23271741
Kaminska M, Bruyat P, Malgorn C et al (2021) Ligand-directed modification of active matrix metalloproteases: activity-based probes with no photolabile group. Angew Chem Int Ed Engl 60:18272–18279
doi: 10.1002/anie.202106117 pubmed: 34096148
Cox J, Mann M (2008) MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26:1367–1372
doi: 10.1038/nbt.1511 pubmed: 19029910
MacLean B, Tomazela DM, Shulman N et al (2010) Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26:966–968
doi: 10.1093/bioinformatics/btq054 pubmed: 20147306 pmcid: 2844992

Auteurs

Carole Malgorn (C)

Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SIMoS, Gif-sur-Yvette, France.

François Becher (F)

Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SPI, Gif-sur-Yvette, France.

Pierrick Bruyat (P)

Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SIMoS, Gif-sur-Yvette, France.

Carole Fruchart-Gaillard (C)

Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SIMoS, Gif-sur-Yvette, France.

Fabrice Beau (F)

Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SIMoS, Gif-sur-Yvette, France.

Sarah Bregant (S)

Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SIMoS, Gif-sur-Yvette, France.

Laurent Devel (L)

Université Paris-Saclay, CEA, INRAE, Département Médicaments et Technologies pour la Santé (DMTS), SIMoS, Gif-sur-Yvette, France. laurent.devel@cea.fr.

Articles similaires

Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Cicer Germination Proteolysis Seeds Plant Proteins
Protein Processing, Post-Translational Humans Blood Coagulation Fibrin Fibrinogen
Humans Breast Neoplasms Female Mass Spectrometry Adipose Tissue

Classifications MeSH